Mammoth Energy Services (TUSK) reports strong Q1 2025 results with 17% revenue growth, $2.7M EBITDA, strategic acquisitions, & expansion in energy markets.

Initiated APOLLO, a double-blind, placebo-controlled, confirmatory trial of bitopertin in adults and adolescents with EPP.

Markets have been pessimistic about LyondellBasell. Read why recent earnings may help shed light on the positives surrounding ...